Literature DB >> 10666000

Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production.

M Niwa1, O Kozawa, H Matsuno, Y Kanamori, A Hara, T Uematsu.   

Abstract

We investigated the mechanism underlying the priming effect of TNF-alpha on fMLP-stimulated superoxide production in human neutrophils. TNF-alpha enhanced fMLP-stimulated superoxide production in a concentration-dependent manner. TNF-alpha also induced sphingomyelin (SM) hydrolysis and increased the formation of its metabolite, sphingosine-1-phosphate (SP-1-P). The treatment of neutrophils with sphingomyelinase also resulted in a similar priming effect. C2 ceramide produced a concentration-dependent inhibition of fMLP-stimulated superoxide production within the concentration range of 1-30 microM. Sphingosine had a dual effect on fMLP-stimulated superoxide generation, exhibiting a priming effect at lower concentrations (0.2-1 microM), but an inhibitory effect at higher concentrations (1-30 microM). SP-1-P (1-30 microM), showed a concentration-dependent enhancement of fMLP stimulated superoxide production. Furthermore, after treating neutrophils with DL-threo-dihydro-sphingosine, a competitive inhibitor of sphingosine kinase, TNF-alpha produced a similar dual effect as observed with sphingosine. These results strongly suggest that SM hydrolysis plays a key role in the intracellular signal transduction mediating the TNF-alpha-mediated priming effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666000     DOI: 10.1016/s0024-3205(99)00587-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.

Authors:  Mel Pilar Espaillat; Richard R Kew; Lina M Obeid
Journal:  Adv Biol Regul       Date:  2016-11-14

2.  Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.

Authors:  Lynn W Maines; Leo R Fitzpatrick; Cecelia L Green; Yan Zhuang; Charles D Smith
Journal:  Inflammopharmacology       Date:  2010-02-12       Impact factor: 4.473

3.  Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion.

Authors:  Manhua Lv; Dayong Zhang; Dawei Dai; Wei Zhang; Liming Zhang
Journal:  Inflamm Res       Date:  2016-03-22       Impact factor: 4.575

4.  Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase.

Authors:  Lynn W Maines; Leo R Fitzpatrick; Kevin J French; Yan Zhuang; Zuping Xia; Staci N Keller; John J Upson; Charles D Smith
Journal:  Dig Dis Sci       Date:  2007-12-04       Impact factor: 3.199

Review 5.  New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.

Authors:  Jan Korbecki; Izabela Gutowska; Ireneusz Kojder; Dariusz Jeżewski; Marta Goschorska; Agnieszka Łukomska; Anna Lubkowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Oncotarget       Date:  2018-01-09

6.  Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils.

Authors:  Johan Bylund; Sara Pellmé; Huamei Fu; Ulf-Henrik Mellqvist; Kristoffer Hellstrand; Anna Karlsson; Claes Dahlgren
Journal:  BMC Cell Biol       Date:  2004-05-24       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.